Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization (Q56567720)

No description defined

Language	Label	Description	Also known as
English	Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization	No description defined

Statements

instance of

scholarly article

0 references

title

Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization (English)

0 references

1 reference

A.Michael Lincoff

1

0 references

language of work or name

English

0 references

publication date

October 1998

0 references

published in

American Journal of Cardiology

0 references

volume

82

0 references

issue

8

0 references

page(s)

36P-42P

0 references

cites work

Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal coronary angioplasty

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900662-6

retrieved

7 January 2021

Identifiers

DOI

10.1016/S0002-9149(98)00662-6

0 references

Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization (Q56567720)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization (Q56567720)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search